Journal article icon

Journal article

Translating molecular advances in Down syndrome and Fragile X syndrome into therapies

Abstract:

Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities with potential disease-modifying properties. The European Down syndrome and other genetic developmental disorders (DSG2D) network joined basic and clinical scientists to foster this research and car...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1016/j.euroneuro.2018.03.006

Authors


Expand authors...
More from this funder
Grant:
ANR-10-IAIHU-06, ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN
Publisher:
Elsevier Publisher's website
Journal:
European Neuropsychopharmacology Journal website
Volume:
28
Issue:
6
Pages:
675-690
Publication date:
2018-06-07
Acceptance date:
2018-03-12
DOI:
EISSN:
1873-7862
ISSN:
0924-977X
Pubs id:
pubs:857658
URN:
uri:fc4ce56d-cde9-4d9f-92f4-4a72046d4e67
UUID:
uuid:fc4ce56d-cde9-4d9f-92f4-4a72046d4e67
Local pid:
pubs:857658

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP